The Rapid Infuser Market is estimated to rise steadily at 4.6% CAGR through 2030

The global rapid infusers market has relatively less impacted by the COVID-19 pandemic, with a new report by Future Market Insights (FMI) estimating market revenues to grow at 4.5% through 2030. While growing focus on advanced and novel care is driving growth, high cost, combined with concerns about efficacy continue to limit adoption.

Key Takeaways

• Market revenues will surpass USD 817 million, with anaesthesia, and emergency healthcare applications being the primary driving factors
• Hospitals will remain the leading end users, while ASCs are also likely to reflect steady growth on the back of growing adoption in outpatient medical procedures.
• Trolley mounted offerings continue to witness market preference, owing to portability and ease of use in hospital settings, accounting for ~70% of market share.
• North America followed by Europe, are leading regional markets for rapid infusers, supported by the massive investments into the healthcare sector, and easier access to new hospital and emergency care technologies.

“The global market for rapid infusers is driven by growing number of surgical procedures and high risk of hypothermia and hypovolemia. This product is also widely considered an important intervention in life-threatening ailments such as sepsis. These issues are major influencers in terms of market development through the forecast period,” said a lead analyst from FMI.

Get Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6716

Covid-19 Impact on Rapid Infusers Market

The COVID-19 pandemic is expected to marginally impact the rapid infusers market. Demand largely remains stable as rapid infusers are standard equipment in most healthcare facilities for critical care applications. The demand for reusable rapid infusers is likely to fall in favor of single-use alternatives, owing to concerns over viral transmission.

Potential disruptions of raw material and component supplies due to lockdown and trade restrictions are concerns. However, the essential natures of the products, makes the industry largely exempt from government restrictions. Demand is unlikely to change substantially even in the post-pandemic period as applications in urology, gynecology, and ICUs continue unabated.

Who is Winning?

In a new report, Future Market Insights has provided comprehensive details on essential business strategies that find roles in the rapid infusers market. Market leaders in the industry have been emphasizing on the expansion of their portfolios with efforts on product research. Also, strategic acquisitions are gaining ground in the industry.

3M, GE Healthcare Inc., ZOLL Medical Corporation, Stryker Corporation, Teleflex Incorporated, Smith’s Group plc, Soma Technology Inc., Smisson-Cartledge Biomedical, and Becton, Dickinson and Company are some of the key companies operating in the rapid infuser market.

More Insights

The Future Market Insights report has given readers a detailed analysis of the global rapid infusers market, with critical information on historical demand (2015-2019) and for forecast statistics (2020 – 2030). The report also encompasses a detailed analysis in terms of costs, pricing, and other major dynamic factors that influence tech developments and production decisions for rapid infusers in varied healthcare applications.

Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-6716

Key Questions Answered by the Report

• What is the size of the rapid infusers market?

The global rapid infusers market is set to reach a valuation of US$ 817 million in 2020. The rapid infusers market is estimated to rise steadily at 4.6% CAGR between 2020 and 2030.

• Which is the largest market for rapid infusers?

The US is the largest market for rapid infusers, owing to the strong presence of leading market players.

• Which are the top companies in global rapid infusers market?

3M, GE Healthcare Inc., Stryker Corp., ZOLL Medical Corp., Smith’s Group Plc, Teleflex Inc., Belmont Instrument Corporation, Becton, Dickinson and Company, Soma Technology Inc., 410 Medical, Smisson-Catledge Biomedical are some of the major players in the rapid infusers market.

• What are the applications of rapid infusers?

Rapid infusers products are used in healthcare facilities to infuse warmed blood or crystalloid fluids for patients with for military and civilian clinicians around the world.

• What are the prospects for the East Asia rapid infusers market?

Countries in the East Asia region are reflecting relatively faster growth than other regional markets on the back of growing investments into medical tourism and favorable government policies towards healthcare infrastructure.

• What is the near-term competitive outlook of the global rapid infusers market?

The global rapid infusers market is moderately consolidated, with investments into product development, with strategic acquisitions and mergers gaining traction.

About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com